A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
P2-167: Induction docetaxel and cisplatin followed of bi-weekly docetaxel with concurrent thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC). A phase II study conducted by the Galician Lung Cancer Group (GLCG)
2007
Journal of Thoracic Oncology
The most satisfactory treatment for patients with locally advanced NSCLC is combination chemotherapy-radiotherapy (CT-RT). The optimal treatment modalities remain to be determined. Methods: 60 patients (pts) with inoperable locally advanced NSCLC, stage IIIAN2/IIIB (no pleural T4), were included in a phase II study with induction chemotherapy consisting of three cycles of Docetaxel 75 mg/m 2 on D1 and Cisplatin 40 mg/m 2 D1-2 every 3 weeks and, if no surgery, then received concurrent CT-RT with
doi:10.1097/01.jto.0000283825.39615.3b
fatcat:jdjggzwhzzefxcsw5ifabbuf3m